Download PDF
Pharmacopsychiatry 2007; 40(3): 103-106
DOI: 10.1055/s-2007-977716
Original Paper

© Georg Thieme Verlag KG Stuttgart · New York

Atypical Antipsychotics and Seborrheic Dermatitis: Three Case Reports

J. Rashid 1 , R. Wang 2 , S. L. Ramer 3
  • 1Department of Psychiatry, Mount Sinai Services, Elmhurst Hospital Center, Elmhurst, New York, USA
  • 2Department of Psychiatry, Mount Sinai School of Medicine, Elmhurst Hospital Center, Elmhurst, New York, USA
  • 3Medical Library, Mount Sinai School of Medicine, Elmhurst Hospital Center, Elmhurst, New York, USA
Further Information

Publication History

received 8. 8. 2006 revised 28.3.2007

accepted 2. 4. 2007

Publication Date:
01 June 2007 (online)

Also available at
    Permissions and Reprints

Abstract

Seborrheic dermatitis (SD) has no diagnostic criteria and its etiology remains unknown. SD is distributed in the areas rich in sebaceous glands. Initially, Malassezia furfur was thought to be the causing agent. Currently, SD is thought as not being proportional to the mean yeast count, but rather as an abnormal host immune response to the yeasts on the skin. There are a variety of topical and systemic antifungal agents available as a remedy. Corticosteroids and ultraviolet B are also used as treatment.

Key words

atypical antipsychotics - seborrheic dermatitis - case reports

References

  • 1 Bergbrant IM, Faegemann J. Seborrheic dermatitis and Pityrosporum ovale; A cultural and immunological study.  Acta Derm Venereol. 1989;  69 332-335
    PubMedSearch in Google Scholar
  • 2 Bonnetblanc JM, Bernard P. Benzoyl peroxide in seborrheic dermatitis.  Arch Dermatol. 1986;  122 752
    CrossrefPubMedSearch in Google Scholar
  • 3 Caputo R, Barbareshi M. Itraconazole: New horizons.  G Ital Dermatol Venereol. 2002;  137 1-7
    PubMedSearch in Google Scholar
  • 4 Cowley NC, Farr PM, Shuster S. The permissive effect of sebum in seborrheic dermatitis: an explanation of the rash in neurological disorders.  Br J Dermatol. 1990;  122 71-76
    PubMedSearch in Google Scholar
  • 5 Cunha PR. Pimecrolimus cream 1% is effective in seborrhoeic dermatitis refractory to treatment with topical corticosteroids.  Acta Dermato-Venereologica. 2006;  86 69-70
    PubMedSearch in Google Scholar
  • 6 Faergemann J. Management of seborrheic dermatitis and pityriasis versicolor.  Am J Clin Dermatol. 2000;  1 75-80
    CrossrefPubMedSearch in Google Scholar
  • 7 Faeremann J. Seborrheic dermatitis and Pityrosporum orbiculare: Treatment of seborrheic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone.  Br J Dermatol. 1986;  114 695-700
    CrossrefPubMedSearch in Google Scholar
  • 8 Faergemann J, Jones JC, Hettler O, Loria Y. Pityrosporum ovale (Malassezia furfur) as the causative agent of seborrheic dermatitis: New treatment options.  Br J Dermatol. 1996;  134 ((Suppl 46)) 12-15
    PubMedSearch in Google Scholar
  • 9 Gupta AK, Madzia SE, Barta R. Etiology and management of seborrheic dermatitis.  Dermatology. 2004;  208 89-93
    CrossrefPubMedSearch in Google Scholar
  • 10 Gupta AK, Nicol KA. Ciclopirox 1% shampoo for treatment of seborrheic Dermatitis.  Int J Dermatol. 2006;  45 66-69
    CrossrefPubMedSearch in Google Scholar
  • 11 Lin AN. Sulphur revisited.  J Am Acad Dermatol. 1988;  18 553-558
    CrossrefPubMedSearch in Google Scholar
  • 12 Mastrolonardo M, Diaferio A, Logroscino G. Seborrheic dermatitis, increased sebum excretion, and Parkinson's disease: a survey of impossible links.  Medical Hypothesis. 2003;  60 907-911
    CrossrefPubMedSearch in Google Scholar
  • 13 Pierard-Franchimont C, Pierard GE. A double blind placebo-controlled study of ketokonazole and desonide gel combination in the treatment of facial seborrheic dermatitis.  Dermatology. 2002;  204 344-347
    CrossrefPubMedSearch in Google Scholar
  • 14 Pirkhammer D, Seeber A, Honigsmann , Ta-new A. Narrow-band ultraviolet B (TL-01) phototherapy is an effective and safe treatment option for patients with severe seborrheic dermatitis.  Br J Dermatol. 2000;  143 964-968
    CrossrefPubMedSearch in Google Scholar
  • 15 Rebora A. Patients with mood depression have a high prevalence of seborrhoeic dermatitis.  Acta Derm Venereol. 1990;  70 432-434
    PubMedSearch in Google Scholar
  • 16 Binder RL, Jonelis FJ. Seborrheic dermatitis: A newly reported side effect of neuroleptics.  J Clin Psychiat. 1984;  45
    PubMedSearch in Google Scholar
  • 17 Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: An overview.  Am Fam Physician. 2006;  741 125-130
    PubMedSearch in Google Scholar
  • 18 Shaw CJ.. , Overview of dermatitis, Up-To-Date 2005.http:// www.utdol.com/application/topic
    PubMed
  • 19 Webster G. Seborrheic dermatitis.  Int. J. Dermatol. 1991;  30 843-844
    PubMedSearch in Google Scholar
  • 20 Wilson CL, Walshe M. Incidence of seborrheic dermatitis in spinal injury patients.  Br J Dermatol. 1988;  33 ((Suppl)) 48
    PubMedSearch in Google Scholar

Correspondence

J. RashidMD 

75 Avenue U

# 1R Brooklyn

New York 11223

USA

Phone: +1/718/946 93 29

Email: javaid.rashid@mssm.edu